The global health crisis is redefining the attractiveness of many end markets served by the chemical industry, raising the cost of doing business (e.g., to ensure public and employee health and safety), and altering global supply chains. Moreover, the drive for scale and greater portfolio focus will fuel the continued restructuring of the chemical industry. We believe these changes mean that more than ever operating companies and other investors need to focus on the fundamentals that will drive value and contribute to the success of M&A activity in this new environment.
In this Insights, we discuss the factors that have contributed to leading performance in the sector, the impact of COVID-19 on the forces driving change in the chemical industry, and the implications for value-creating M&A strategies and programs.
